1. Dicpinigaitis PV. Short- and long-term reproducibility of capsaicin cough challenge testing. Pulm Pharmacol Ther. 2003. 16:61–65.
2. Siracusa A, Desrosiers M, Marabini A. Epidemiology of occupational rhinitis: prevalence, aetiology and determinants. Clin Exp Allergy. 2000. 30:1519–1534.
3. Moscato G, Vandenplas O, Van Wijk RG, Malo JL, Perfetti L, Quirce S, Walusiak J, Castano R, Pala G, Gautrin D, De Groot H, Folletti I, Yacoub MR, Siracusa A. EAACI position paper on occupational rhinitis. Respir Res. 2009. 10:16.
4. Wolf G, Anderhuber W, Hauser-Kronberger C, Saria A. Treatment of nonspecific hyper-reflectory rhinopathy (vasomotor rhinitis) with capsaicin. Laryngorhinootologie. 1995. 74:289–293.
5. Didier A, Kowalski ML, Jay J, Kaliner MA. Neurogenic inflammation, vascular permeability, and mast cells. Capsaicin desensitization fails to influence IgE-anti-DNP induced vascular permeability in rat airways. Am Rev Respir Dis. 1990. 141:398–406.
6. Thong BY. Update on the management of antibiotic allergy. Allergy Asthma Immunol Res. 2010. 2:77–86.
7. Stjärne P, Rinder J, Hedén-Blomquist E, Cardell LO, Lundberg J, Zetterström O, Anggård A. Capsaicin desensitization of the nasal mucosa reduces symptoms upon allergen challenge in patients with allergic rhinitis. Acta Otolaryngol. 1998. 118:235–239.
8. Philip G, Sanico AM, Togias A. Inflammatory cellular influx follows capsaicin nasal challenge. Am J Respir Crit Care Med. 1996. 153:1222–1229.
9. Barnes PJ. Neurogenic inflammation and asthma. J Asthma. 1992. 29:165–180.
10. Kim D, Baraniuk JN. Neural aspects of allergic rhinitis. Curr Opin Otolaryngol Head Neck Surg. 2007. 15:268–273.
11. Bascom R, Kagey-Sobotka A, Proud D. Effect of intranasal capsaicin on symptoms and mediator release. J Pharmacol Exp Ther. 1991. 259:1323–1327.
12. Seitz CS, Bröcker EB, Trautmann A. Diagnostic testing in suspected fluoroquinolone hypersensitivity. Clin Exp Allergy. 2009. 39:1738–1745.
13. Sachs B, Riegel S, Seebeck J, Beier R, Schichler D, Barger A, Merk HF, Erdmann S. Fluoroquinolone-associated anaphylaxis in spontaneous adverse drug reaction reports in Germany: differences in reporting rates between individual fluoroquinolones and occurrence after first-ever use. Drug Saf. 2006. 29:1087–1100.
14. Fujimoto S, Mori M, Tsushima H, Kunimatsu M. Capsaicin-induced, capsazepine-insensitive relaxation of the guinea-pig ileum. Eur J Pharmacol. 2006. 530:144–151.
15. Fujimoto S, Mori M. Characterization of capsaicin-induced, capsazepine-insensitive relaxation of ileal smooth muscle of rats. Eur J Pharmacol. 2004. 487:175–182.
16. Roche N, Lurie A, Authier S, Dusser DJ. Nasal response to capsaicin in patients with allergic rhinitis and in healthy volunteers: effect of colchicine. Am J Respir Crit Care Med. 1995. 151:1151–1158.
17. Sanico AM, Atsuta S, Proud D, Togias A. Dose-dependent effects of capsaicin nasal challenge: in vivo evidence of human airway neurogenic inflammation. J Allergy Clin Immunol. 1997. 100:632–641.